NICE guidance in schizophrenia: How generalisable are drug trials?

NICE guidance in schizophrenia: How generalisable are drug trials?

Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...

Bibliografske podrobnosti
Glavni avtor:	Burns, T
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

Diagnosis and management of endometriosis: summary of NICE guidance
od: Kuznetsov, L, et al.
Izdano: (2017)

Commentary: Controversies in NICE guidance on chronic kidney disease.
od: Landray, M, et al.
Izdano: (2008)

Management of hip fracture in adults: summary of NICE guidance.
od: Ftouh, S, et al.
Izdano: (2011)

Commentary: Controversies in NICE guidance on chronic kidney disease
od: Landray, M, et al.
Izdano: (2008)

Reduction in twin stillbirth following implementation of NICE guidance
od: Khalil, A, et al.
Izdano: (2020)

NICE guidance for off-pump CABG: turn off the pump.
od: Falk, V, et al.
Izdano: (2011)

Assessment and management of bipolar disorder: Summary of updated NICE guidance
od: Kendall, T, et al.
Izdano: (2014)

Chronic heart failure in adults: summary of updated NICE guidance
od: Real, J, et al.
Izdano: (2018)

Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance.
od: Pilling, S, et al.
Izdano: (2013)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance.
od: Visintin, C, et al.
Izdano: (2010)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance
od: Visintin, C, et al.
Izdano: (2010)

Venous thromboembolism management and the new NICE guidance: what the busy GP needs to know
od: Jones, N, et al.
Izdano: (2021)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance
od: Visintin, C, et al.
Izdano: (2010)

Omalizumab: NICE to USE you, to LOSE you NICE.
od: Bush, A, et al.
Izdano: (2013)

Learn to be nice
od: Abd Razak, Dzulkifli
Izdano: (2007)

Berry nice
od: Filzah Shafiee
Izdano: (2020)

If NICE was in the USA
od: Kendall, T, et al.
Izdano: (2009)

Commentary: NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care
od: Butler, C, et al.
Izdano: (2008)

Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
od: Curtis, HJ, et al.
Izdano: (2018)

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).
od: Gaebel, W, et al.
Izdano: (2010)

The National Institute for Health and Care Excellence (NICE) guidance on bladder cancer; a step in the right direction?
od: Trainor, S, et al.
Izdano: (2017)

Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
od: Armitage, J
Izdano: (2008)

Commentary: Controversies in NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care.
od: Butler, C, et al.
Izdano: (2008)

Parameterization of nice polynomials
od: Anton, Hozjee
Izdano: (2018)

Nice to meat you
od: Ng, Brenlyn Jie Jia, et al.
Izdano: (2020)

Where now with NICE?
od: Dennison, E, et al.
Izdano: (2011)

Response from NICE.
od: Pollard, A, et al.
Izdano: (2011)

Where now with NICE?
od: Dennison, E, et al.
Izdano: (2011)

Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
od: Curtis, H, et al.
Izdano: (2018)

(PREMIER POSTER - AWARD CANDIDATE) TREATMENT GUIDANCE IN WOMEN WITH WRIST FRACTURE: NICE TA161, NOGG AND FRAX
od: Weeks, C, et al.
Izdano: (2009)

Generalised topological features and machine learning in drug design
od: Ti, Tze Hong
Izdano: (2020)

How to make a compelling submission to NICE: tips for sponsoring organisations.
od: Burls, A, et al.
Izdano: (2003)

NICE and new: appraising innovation.
od: Ferner, R, et al.
Izdano: (2010)

Hypertension in pregnancy: the NICE guidelines.
od: Redman, C
Izdano: (2011)

Judicial reform and the treaty of Nice
od: Johnston, AC
Izdano: (2001)

“Don’t shoot the messengers…..”: The new NICE guidance for the prevention of venous thromboembolism in adults – fake news or a real opportunity?
od: Griffin, XL, et al.
Izdano: (2018)

Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
od: Morrell, L, et al.
Izdano: (2018)

Interactive treatment in schizophrenia
od: Burns, T
Izdano: (2005)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
od: Leucht, S, et al.
Izdano: (2019)

Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.
od: Bethel, M, et al.
Izdano: (2012)